| 注册
首页|期刊导航|中国药房|路径分析在药物经济学评价中的应用

路径分析在药物经济学评价中的应用

潘岳松 彭晓霞 杜忠东

中国药房2011,Vol.22Issue(38):3566-3568,3.
中国药房2011,Vol.22Issue(38):3566-3568,3.

路径分析在药物经济学评价中的应用

Application of Path Analysis in Pharmacoeconomics

潘岳松 1彭晓霞 2杜忠东1

作者信息

  • 1. 首都医科大学附属北京儿童医院,北京市100045
  • 2. 首都医科大学公共卫生与家庭医学学院流行病学与卫生统计学系,北京市100069
  • 折叠

摘要

Abstract

OBJECTIVE: To explore the application of path analysis in pharmacoeconomics. METHODS: The data in clinical trial were fitted by path analysis model. The influencing factors and their relationships were revealed by parameter estimation in the model, and then the pharmacoeconomics was evaluated. RESULTS: The relationship of therapeutic regimen, therapeutic effectiveness and hospitalization cost were reflected by the path analysis model quantitatively and objectively. The goodness of fit index (GFI) of the model was 0.943 2, and the adjustive goodness of fit index (AGFI) was 0.858 1, which proclaiming that the fitting of the model was good. CONCLUSION: Pharmacoeconomics evaluation might be conducted effectively through path analysis.

关键词

路径分析/药物经济学/临床试验

Key words

Path analysis/ Pharmacoeconomics/ Clinical trial

分类

医药卫生

引用本文复制引用

潘岳松,彭晓霞,杜忠东..路径分析在药物经济学评价中的应用[J].中国药房,2011,22(38):3566-3568,3.

基金项目

中国医师协会资助课题(CMDA20090506) (CMDA20090506)

中国药房

OACSCDCSTPCD

1001-0408

访问量0
|
下载量0
段落导航相关论文